首页> 外文期刊>International journal of hematology >Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography
【24h】

Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography

机译:基于免疫色谱的异基因造血干细胞移植后被诊断为诺如病毒性胃肠炎的患者的特征和结果

获取原文
获取原文并翻译 | 示例
           

摘要

Norovirus gastroenteritis (NV-GE) is a highly transmittable disease that can lead to fatal outcomes in vulnerable populations including patients after hematopoietic stem cell transplantation (HSCT). Prompt detection of NV is therefore important for HSCT recipients. Immunochromatography (IC) can be used to easily and rapidly diagnose NV-GE by detecting NV antigens. In this study, we examined 642 stool specimens in patients who developed diarrhea after allogeneic HSCT between January 2007 and June 2011. NV was detected in 10 of 350 (2.9 %) HSCT recipients. The median onset of symptoms was 36 days (range 3-93) after HSCT. The median duration of symptoms was 42 days (3-135). A second or subsequent allogeneic HSCT was associated with a higher incidence of NV-GE (P = 0.034). Of four patients who underwent colonoscopy, two showed intestinal graft-versus-host disease (GVHD) histopathology, whereas the other two showed no evidence of GVHD, and thus no need for intensified immunosuppression. None of the patients died of NV-GE. In conclusion, IC may be useful in the differential diagnosis of diarrhea after allogeneic HSCT, and could enable the appropriate adjustment of immunosuppressive drugs and prompt preventive measures.
机译:诺如病毒胃肠炎(NV-GE)是一种高度可传播的疾病,可在包括造血干细胞移植(HSCT)在内的脆弱人群中导致致命后果。因此,及时检测NV对于HSCT接收者很重要。免疫色谱法(IC)可用于通过检测NV抗原轻松快速地诊断NV-GE。在这项研究中,我们检查了2007年1月至2011年6月间异基因HSCT后腹泻患者的642个粪便标本。在350名(2.9%)HSCT接受者中,有10人检测到NV。 HSCT后中位症状发作为36天(范围3-93)。症状的中位持续时间为42天(3-135)。第二次或以后的同种异体造血干细胞移植与NV-GE发生率更高有关(P = 0.034)。在接受结肠镜检查的四名患者中,有两名显示了肠移植物抗宿主病(GVHD)的组织病理学,而其他两名则没有显示GVHD的证据,因此不需要加强免疫抑制。没有患者死于NV-GE。总之,IC可以用于异基因HSCT后的腹泻鉴别诊断,并可以适当调整免疫抑制药物并及时采取预防措施。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号